News and Announcements
Shivom Successfully Raised $33 Million in the Private and Pre-sale Round and is Now Only $2 Million Away From Reaching Hardcap
- Published April 29, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Shivom’s Presale has now closed
- Closed the sale with 33 $ million dollars
- Main crowdsale that begins on May 3rd
Shivom’s Presale has now closed and we cannot thank you enough for making it an overwhelming success! We closed the sale with 33 $ million dollars and are now all geared up for the main crowdsale that begins on May 3rd, 2018 (next week!) We are now one step closer to achieving our targets and we couldn’t have reached this far without your continued support.
The success of our presale is a great encouragement for us to keep striving to reach our goals of building the world’s best platform to improve the global healthcare system. With your continued supportwe are well on our way to begin developing our platform for safe and secure DNA sequencing and data storage and sharing for advancement of precision medicine.
Shivom’s Journey
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
Ecosystems Over Exit: Callum Laing on Disrupting Small Business M&A
At Emergence Singapore, Callum Laing of Veblen Director Program presented a bold new vision for small business M&A: “Ecosystems Over Exit.” He shared how his Unity Group takes cash-generating businesses public, focusing on growth over immediate founder exit. Discover his unique approach, how interconnected ecosystems drive massive deal flow, and a three-step framework for any business to amplify reach and capital raising.
Report on the Impact of the Proposed Unrealised Capital Gains Tax on Investment in Key Sectors
A recent survey of investors and company leaders reveals significant concerns about the proposed Unrealised Capital Gains Tax (UCGT) in Australia. Over 84% indicate it would negatively impact investment in vital renewable energy, sustainability, and life science sectors, with 82% believing it would discourage long-term holdings. The report highlights the critical role of SMSF investors in early-stage funding and urges policymakers to reconsider the tax’s potential to stifle innovation and economic growth.
Ray Dalio: “Worse Than a Recession” if Global Imbalances Aren’t Addressed
Ray Dalio, the influential founder of the world’s largest hedge fund, Bridgewater Associates, has issued a grave warning about the global economic and geopolitical landscape, cautioning that without decisive action, the world could face a crisis “worse than a normal recession.” Speaking on “Meet the Press” ahead of the June release of his new book, […]
Backed By Leading Investment Groups and Family Offices
